'Univesiti Fakafonua 'a Tonga -
Tonga National University
Ko e Mo’oni, Ko e Totonu mo e Tau’ataina - Truth, Justice, Freedom



Amazon cover image
Image from Amazon.com

A Practical handbook on the pharmacovigilance of antimalarial medicines. / by World Health Organization.

Contributor(s): Material type: TextTextPublisher: Geneva, Switzerland : World Health Organization, [2008]Copyright date: ©2008Description: viii, 108 pages : illustrations (chiefly color) ; 22 cmContent type:
  • text
Media type:
  • unmediated
Carrier type:
  • volume
ISBN:
  • 9789241547499
  • 9241547499
Subject(s):
Contents:
A. Introduction -- B. Passive or active pharmacovigilance? -- D. Cohort event monitoring -- E. Data processing -- F. Special types of event -- G. Relationship/causality assessment -- H. Signal identification -- I. Strengthening the signal -- J. Identifying risk factors -- K. Analyses -- L. Differences between spontaneous reporting and cohort event monitoring -- M. Organization -- N. Communication -- Annex 1. CEM reporting form sides A and B -- Annex 2. Coding sheet--sample from the IMMP -- Annex 3. Major Clinical Categories IMMP Events Dictionary -- Annex 4. Clinical Category Eyes, IMMP events dictionary -- Annex 5. Events collation, Circulatory, omeprazole--IMMP sample listing -- Annex 6. Comparative events profiles (celecoxib and rofecoxib)--IMMP -- Annex 7A. Pregnancy enquiry questonnaire -- Annex 7B. Pregnancy progress questionnaire -- Annex 7C. Pregnancy outcome questionnaire -- Annex 8. Deaths (as events) with omeprazole--IMMP sample listing -- Annex 9. Eye events listing from IMMP- -- Annex 10. Drug-drug associations with celecoxib--IMMP sample listing -- Annex 11. A selection of helpful web sites -- Annex 12. Resources -- Annex 13. Contacts -- Annex 14. The importance of communication.
Summary: "This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antimalarials. It is intended to be a source of practical advice for Pharmacovigilance Centres." - p. 9.
Tags from this library: No tags from this library for this title.
Star ratings
    Average rating: 0.0 (0 votes)

A. Introduction -- B. Passive or active pharmacovigilance? -- D. Cohort event monitoring -- E. Data processing -- F. Special types of event -- G. Relationship/causality assessment -- H. Signal identification -- I. Strengthening the signal -- J. Identifying risk factors -- K. Analyses -- L. Differences between spontaneous reporting and cohort event monitoring -- M. Organization -- N. Communication -- Annex 1. CEM reporting form sides A and B -- Annex 2. Coding sheet--sample from the IMMP -- Annex 3. Major Clinical Categories IMMP Events Dictionary -- Annex 4. Clinical Category Eyes, IMMP events dictionary -- Annex 5. Events collation, Circulatory, omeprazole--IMMP sample listing -- Annex 6. Comparative events profiles (celecoxib and rofecoxib)--IMMP -- Annex 7A. Pregnancy enquiry questonnaire -- Annex 7B. Pregnancy progress questionnaire -- Annex 7C. Pregnancy outcome questionnaire -- Annex 8. Deaths (as events) with omeprazole--IMMP sample listing -- Annex 9. Eye events listing from IMMP- -- Annex 10. Drug-drug associations with celecoxib--IMMP sample listing -- Annex 11. A selection of helpful web sites -- Annex 12. Resources -- Annex 13. Contacts -- Annex 14. The importance of communication.

"This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antimalarials. It is intended to be a source of practical advice for Pharmacovigilance Centres." - p. 9.

The OPAC was designed by Rachel Lesieli Hollis using what remains of the HTML coding she learned long ago.